Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years

Update your browser to view ScienceDirect.

Request details:

Request ID: 8e9e063d2b70d01d-LAX
IP: 116.62.10.13
UTC time: 2024-11-28T23:09:13+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4